Clinuvel Pharmaceuticals Ltd Cash Flow Quality Index
Clinuvel Pharmaceuticals Ltd cash flow quality index. Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow Quality Index of 1.20x as of December 2025. Operating cash flow of AU$12.52 Million exceeds net income of AU$10.44 Million, indicating high earnings quality where cash backs reported profits. See Clinuvel Pharmaceuticals Ltd (CUV) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Clinuvel Pharmaceuticals Ltd (2017–2025)
Cash flow quality index of Clinuvel Pharmaceuticals Ltd from 2017 to 2025. Historical Cash Flow Quality Index for Clinuvel Pharmaceuticals Ltd across 9 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore CUV operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.
Clinuvel Pharmaceuticals Ltd Cash Flow Quality Index by Year (2017–2025)
Clinuvel Pharmaceuticals Ltd cash flow quality index by year from 2017 to 2025. Year-by-year earnings quality comparison for Clinuvel Pharmaceuticals Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Clinuvel Pharmaceuticals Ltd.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.14x | AU$41.10 Million | AU$36.17 Million | ▲ +9.3% |
| 2024 | 1.04x | AU$37.05 Million | AU$35.64 Million | ▼ -13.8% |
| 2023 | 1.21x | AU$36.91 Million | AU$30.60 Million | ▼ -36.8% |
| 2022 | 1.91x | AU$39.87 Million | AU$20.88 Million | ▲ +145.2% |
| 2021 | 0.78x | AU$19.26 Million | AU$24.73 Million | ▼ -17.4% |
| 2020 | 0.94x | AU$14.19 Million | AU$15.05 Million | ▼ -7.4% |
| 2019 | 1.02x | AU$18.46 Million | AU$18.13 Million | ▲ +15.1% |
| 2018 | 0.88x | AU$11.69 Million | AU$13.22 Million | ▼ -36.0% |
| 2017 | 1.38x | AU$9.92 Million | AU$7.18 Million | — |